While polling data suggests many Americans remain anxious and skeptical about ObamaCare, the early big winners of the president’s signature law include investors, lawyers, consultants and purveyors of new technology.

Since March 23, 2010, when it was signed into law, the health care sector of stocks in the S&P 500 has increased in value by 50 percent. Gilead Sciences, a California-based drug maker with 5,000 workers, has seen its stock price explode by 157 percent in the last three and a half years.

Health insurers Cigna, Aetna and United Health have each seen healthy gains since President Obama signed the reform measure. Those companies as well as hospital operators Tenet Healthcare and Health Management Associates have seen stock gains far above the S&P’s overall 16.9 percent jump.

On a smaller scale, lawyers with expertise understanding ObamaCare are winners, too.

Arthur Tacchino grew up near Philadelphia and says he always wanted to be a lawyer. He earned his law degree in 2010 and while some of his fellow graduates struggled to find work, Tacchino says he’s fortunate to have stumbled into a job asking him to become an ObamaCare expert.

Continue reading →